“It’s exciting to be part of a team harnessing the potential of the human immune system to create life-changing T cell therapies for patients in need and sharing our advances with the investment community.”
Heather Savelle is our Vice President, Investor Relations. Heather brings to TScan over 20 years of experience in corporate communications and investor relations for the biotechnology and life sciences industry.
Prior to joining TScan, Heather was a Managing Director at Argot Partners, LLC where she provided strategic communications counsel to biotechnology companies across all stages of development and commercialization. Before joining Argot Partners, she was Senior Vice President at MacDougall Biomedical Communications. Prior to that, Heather held positions of increasing responsibility for various small, mid- and large cap biotechnology and life sciences companies including Targacept, Inc., Repligen Corporation, Dynogen Pharmaceuticals, Inc., and Millennium Pharmaceuticals (now part of Takeda Oncology). Heather holds a B.A. in Sociology from the University of California, Santa Barbara.
Outside of TScan, Heather enjoys traveling with her sons, baking, reading, hiking, and rescuing dogs.